Alexis is an associate in Cooley’s corporate practice group. She advises clients through various stages of the business life cycle in matters ranging from corporate governance and venture capital financings to M&A and the private placement of securities.
Avid Bioservices Announces $1.1 Billion Acquisition by GHO Capital Partners and Ampersand Capital Partners
November 6, 2024
Cooley advised Avid Bioservices (Nasdaq: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, on its definitive merger agreement to be acquired by funds managed by GHO Capital Partners and Ampersand Capital Partners in an all-cash transaction valued at approximately $1.1 billion.
GeBBS Healthcare Solutions Announces Sale to EQT Private Capital Asia
September 9, 2024
Cooley advised GeBBS Healthcare Solutions, a global provider of healthcare outsourcing solutions, and ChrysCapital, a top India-focused private equity firm, on the agreement for BPEA Private Equity Fund VIII (EQT Private Capital Asia) to acquire a controlling beneficial interest in GeBBS from ChrysCapital.